Sandiala, Beltran A.
HRN: 02-42-33 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2024
CEFTRIAXONE 1G (VIAL)
05/04/2024
05/11/2024
IV DRIP
2gm
OD
Infected Punctured Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes